| P2093 | author name string | Chan Young Shin | |
| | Hyun Ho Park | |
| | So Young Choi | |
| | Sung Hoon Lee | |
| | Jong Hyuk Lee | |
| | Seung Hyo Jung | |
| | Yeonsun Jin | |
| | Hyun Myung Ko | |
| P2860 | cites work | Genes learn from stress: how infantile trauma programs us for depression | Q51060936 |
| | Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study | Q57260389 |
| | Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome | Q64325257 |
| | Antiepileptic drugs as human teratogens | Q80832556 |
| | Searching for ways out of the autism maze: genetic, epigenetic and environmental clues | Q22251430 |
| | Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro | Q24544290 |
| | MicroRNAs: regulators of neuronal fate | Q24596859 |
| | Identification of pro- and mature brain-derived neurotrophic factor in human saliva | Q24644115 |
| | MeCP2, a key contributor to neurological disease, activates and represses transcription | Q24647533 |
| | Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications | Q24649095 |
| | MicroRNA and Posttranscriptional Dysregulation in Psychiatry | Q26864325 |
| | BDNF deregulation in Rett syndrome | Q27005901 |
| | The language of covalent histone modifications | Q27860931 |
| | Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders | Q28086869 |
| | Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex | Q28208046 |
| | Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA | Q28256854 |
| | Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival | Q28257331 |
| | In utero exposure to valproic acid and autism — A current review of clinical and animal studies | Q28285222 |
| | Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study | Q28387103 |
| | Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression | Q28480965 |
| | Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity | Q28581097 |
| | DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation | Q28591717 |
| | MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. | Q28909710 |
| | Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations | Q28941188 |
| | Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen | Q29616224 |
| | Autism spectrum disorders: developmental disconnection syndromes | Q29616818 |
| | Non-coding RNAs in human disease | Q29618039 |
| | Beyond Widespread Mecp2 Deletions to Model Rett Syndrome: Conditional Spatio-Temporal Knockout, Single-Point Mutations and Transgenic Rescue Mice | Q30450914 |
| | Increased BDNF expression in fetal brain in the valproic acid model of autism | Q33560820 |
| | Prenatal exposure to valproic acid increases miR-132 levels in the mouse embryonic brain | Q33850875 |
| | Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism | Q33987401 |
| | Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease | Q34065279 |
| | Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants | Q34211475 |
| | Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity | Q47445768 |
| | Blood BDNF concentrations reflect brain-tissue BDNF levels across species | Q48138873 |
| | Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments | Q48144692 |
| | Molecular biology. MeCP2 repression goes nonglobal | Q48156888 |
| | Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients | Q48188457 |
| | Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons | Q48193624 |
| | Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder | Q48203070 |
| | Transport of brain-derived neurotrophic factor across the blood-brain barrier | Q48307102 |
| | Brain-derived neurotrophic factor participates in determination of neuronal laminar fate in the developing mouse cerebral cortex. | Q48331550 |
| | Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse. | Q48487114 |
| | Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets | Q48528817 |
| | Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes | Q48649203 |
| | The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression | Q48667829 |
| | NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression | Q48894918 |
| | Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy | Q50305480 |
| | Histone deacetylase activity is required for embryonic stem cell differentiation | Q34294057 |
| | Characteristics of fetal anticonvulsant syndrome associated autistic disorder. | Q34444066 |
| | Experimental models of Rett syndrome based on Mecp2 dysfunction. | Q34686591 |
| | Tissue plasminogen activator and glial function | Q35923428 |
| | Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors. | Q35978159 |
| | Peripheral brain-derived neurotrophic factor in autism spectrum disorder: a systematic review and meta-analysis | Q36099444 |
| | Altered Balance of Proteolytic Isoforms of Pro-Brain-Derived Neurotrophic Factor in Autism | Q36164551 |
| | MicroRNAs tune cerebral cortical neurogenesis | Q36223983 |
| | MeCP2 Is Critical for Maintaining Mature Neuronal Networks and Global Brain Anatomy during Late Stages of Postnatal Brain Development and in the Mature Adult Brain | Q36288388 |
| | MicroRNAs in neuronal function and dysfunction | Q36589809 |
| | Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons | Q36965800 |
| | Neuro-archaeology: pre-symptomatic architecture and signature of neurological disorders | Q37308350 |
| | The conundrums of understanding genetic risks for autism spectrum disorders | Q37613535 |
| | c-Jun Amino-Terminal Kinase is Involved in Valproic Acid-Mediated Neuronal Differentiation of Mouse Embryonic NSCs and Neurite Outgrowth of NSC-Derived Neurons | Q37732914 |
| | Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. | Q37926892 |
| | Autism genetics: searching for specificity and convergence | Q38031004 |
| | A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP. | Q38339610 |
| | Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation | Q38461332 |
| | Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration | Q39008341 |
| | Changes in the Histone Acetylation Patterns during the Development of the Nervous System | Q39034796 |
| | Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations | Q39498014 |
| | Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. | Q40232814 |
| | Valproic acid mediates miR-124 to down-regulate a novel protein target, GNAI1. | Q40373300 |
| | DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. | Q40378884 |
| | Histone Deacetylase Inhibitor Activates the WAF1/Cip1 Gene Promoter through the Sp1 Sites | Q41066638 |
| | Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation | Q41808615 |
| | Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells | Q41948991 |
| | Strain-specific BDNF expression of rat primary astrocytes | Q42467616 |
| | Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells | Q42483304 |
| | Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear | Q42628513 |
| | Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism. | Q42956192 |
| | Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid | Q42984563 |
| | Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. | Q43290175 |
| | Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism | Q44967603 |
| | Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity | Q45108268 |
| | Effect of HDAC inhibitors on neuroprotection and neurite outgrowth in primary rat cortical neurons following ischemic insult. | Q45769540 |
| | tPA Regulates Neurite Outgrowth by Phosphorylation of LRP5/6 in Neural Progenitor Cells | Q45902163 |
| | Is autism caused by early hyperactivity of brain-derived neurotrophic factor? | Q46489573 |
| | Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment | Q46724820 |
| | The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. | Q46958808 |
| | Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites. | Q46974619 |
| | Serum neurotrophin concentrations in autism and mental retardation: a pilot study | Q47424215 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P2507 | corrigendum / erratum | Corrigendum to: Dual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells | Q60933409 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 679-688 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Korean Journal of Physiology and Pharmacology | Q15757587 |
| P1476 | title | Dual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells | |
| P478 | volume | 22 | |